piracetam has been researched along with Chronic Liver Failure in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dosage of immunosuppressants did not change before and after levetiracetam treatment, and there were no changes in hematological and biochemical data before and after treatment." | 5.42 | Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation. ( Chen, CL; Chen, NC; Chuang, YC; Lin, CH; Lin, TK; Tsai, MH, 2015) |
| " The dosage of immunosuppressants did not change before and after levetiracetam treatment, and there were no changes in hematological and biochemical data before and after treatment." | 1.42 | Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation. ( Chen, CL; Chen, NC; Chuang, YC; Lin, CH; Lin, TK; Tsai, MH, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CH | 1 |
| Chen, CL | 1 |
| Lin, TK | 1 |
| Chen, NC | 1 |
| Tsai, MH | 1 |
| Chuang, YC | 1 |
1 other study available for piracetam and Chronic Liver Failure
| Article | Year |
|---|---|
Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation.
Topics: Adult; Anticonvulsants; Drug Monitoring; End Stage Liver Disease; Female; Humans; Levetiracetam; Liv | 2015 |